Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Buy
12,599
+407
+3% +$128K 0.05% 139
2026
Q1
$4.01M Sell
12,192
-254
-2% -$91.2K 0.06% 134
2025
Q4
$4.37M Sell
12,446
-61
-0.5% -$22.2K 0.06% 119
2025
Q3
$4.62M Sell
12,507
-78
-0.6% -$30.1K 0.07% 111
2025
Q2
$4.98M Sell
12,585
-249
-2% -$93.2K 0.08% 101
2025
Q1
$4.78M Sell
12,834
-30
-0.2% -$11.4K 0.08% 106
2024
Q4
$4.63M Sell
12,864
-193
-1% -$71.5K 0.08% 106
2024
Q3
$4.72M Buy
13,057
+186
+1% +$64.2K 0.08% 112
2024
Q2
$4.38M Sell
12,871
-50
-0.4% -$16.9K 0.08% 111
2024
Q1
$4.62M Sell
12,921
-7
-0.1% -$2.35K 0.09% 111
2023
Q4
$3.87M Buy
12,928
+2,756
+27% +$774K 0.08% 118
2023
Q3
$2.78M Buy
10,172
+370
+4% +$106K 0.07% 131
2023
Q2
$2.99M Buy
9,802
+15
+0.2% +$4.33K 0.07% 123
2023
Q1
$2.79M Sell
9,787
-156
-2% -$41.4K 0.07% 122
2022
Q4
$2.43M Sell
9,943
-141
-1% -$32K 0.06% 128
2022
Q3
$2.04M Sell
10,084
-121
-1% -$25.5K 0.06% 137
2022
Q2
$2.03M Sell
10,205
-83
-0.8% -$19.5K 0.05% 146
2022
Q1
$2.75M Sell
10,288
-89
-0.9% -$23K 0.06% 132
2021
Q4
$2.77M Sell
10,377
-40
-0.4% -$10.5K 0.06% 140
2021
Q3
$2.75M Buy
10,417
+25
+0.2% +$6.68K 0.07% 142
2021
Q2
$2.7M Sell
10,392
-44
-0.4% -$11.3K 0.07% 147
2021
Q1
$2.54M Buy
10,436
+6
+0.1% +$1.44K 0.07% 147
2020
Q4
$2.56M Sell
10,430
-500
-5% -$113K 0.07% 142
2020
Q3
$2.28M Buy
10,930
+270
+3% +$52.5K 0.07% 138
2020
Q2
$1.92M Buy
10,660
+1,950
+22% +$360K 0.06% 139
2020
Q1
$1.45M Sell
8,710
-235
-3% -$45.9K 0.06% 141
2019
Q4
$1.88M Buy
8,945
+18
+0.2% +$3.74K 0.06% 147
2019
Q3
$1.93M Buy
8,927
+57
+0.6% +$12.2K 0.07% 144
2019
Q2
$1.82M Buy
+8,870
New +$1.69M 0.07% 147
2018
Q4
Sell
-7,038
Closed -$1.25M 294
2018
Q3
$1.25M Sell
7,038
-615
-8% -$105K 0.06% 164
2018
Q2
$1.29M Buy
7,653
+446
+6% +$75K 0.06% 159
2018
Q1
$1.16M Sell
7,207
-139
-2% -$22.4K 0.05% 168
2017
Q4
$1.14M Buy
7,346
+630
+9% +$96.1K 0.05% 181
2017
Q3
$954K Buy
6,716
+2,625
+64% +$376K 0.04% 186
2017
Q2
$567K Sell
4,091
-25
-0.6% -$3.43K 0.03% 227
2017
Q1
$542K Buy
4,116
+475
+13% +$60K 0.02% 220
2016
Q4
$437K Buy
3,641
+67
+2% +$7.71K 0.02% 231
2016
Q3
$416K Sell
3,574
-1,200
-25% -$140K 0.02% 230
2016
Q2
$572K Buy
4,774
+30
+0.6% +$3.35K 0.03% 210
2016
Q1
$509K Sell
4,744
-41
-0.9% -$4.04K 0.03% 208
2015
Q4
$444K Buy
4,785
+318
+7% +$30.4K 0.02% 225
2015
Q3
$420K Hold
4,467
0.02% 219
2015
Q2
$427K Hold
4,467
0.02% 225
2015
Q1
$412K Sell
4,467
-42
-0.9% -$3.91K 0.02% 229
2014
Q4
$425K Sell
4,509
-500
-10% -$44.4K 0.02% 235
2014
Q3
$404K Buy
5,009
+200
+4% +$16.5K 0.02% 230
2014
Q2
$405K Sell
4,809
-63
-1% -$5.14K 0.02% 226
2014
Q1
$397K Sell
4,872
-13
-0.3% -$1.03K 0.02% 226
2013
Q4
$367K Hold
4,885
0.02% 225
2013
Q3
$330K Sell
4,885
-100
-2% -$6.9K 0.02% 239
2013
Q2
$322K Buy
+4,985
New +$331K 0.02% 235

Other funds holding SYK

HM Payson & Co's SYK Position: Q2 2026 in Review

HM Payson & Co increased its Stryker (SYK) stake by 3.3% in Q2 2026, buying an estimated $128K and bringing the position to 12,599 shares worth $3.97M. The position accounts for 0.05% of the portfolio, ranked #139.

HM Payson & Co first reported a position in SYK in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.98M in Q2 2025. 795 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • HM Payson & Co held 12,599 shares of Stryker worth $3.97M as of Q2 2026.
  • HM Payson & Co bought 407 Stryker shares in Q2 2026, an estimated $128K.
  • Stryker made up 0.05% of HM Payson & Co's portfolio in Q2 2026, its #139 holding.
  • HM Payson & Co first reported a position in Stryker in Q2 2013 and has held it in 51 quarters since.
  • HM Payson & Co's Stryker position peaked at $4.98M in Q2 2025.
  • 795 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.